Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-21-003100
Filing Date
2021-02-26
Accepted
2021-02-26 06:04:41
Documents
6
Period of Report
2021-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp146697_6k.htm 6-K 13343
2 EXHIBIT 99.1 dp146697_ex9901.htm EX-99.1 95946
3 EXHIBIT 99.2 dp146697_ex9902.htm EX-99.2 7115
4 GRAPHIC image_026.jpg GRAPHIC 2322
5 GRAPHIC image_029.jpg GRAPHIC 67160
6 GRAPHIC image_030.jpg GRAPHIC 103970
  Complete submission text file 0000950103-21-003100.txt   356641
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 21683588
SIC: 2834 Pharmaceutical Preparations